Cboe UK GBp

Dr. Martens plc (DOCSL.XC)

78.95
-2.00
(-2.47%)
At close: June 11 at 4:29:57 PM GMT+1
Loading Chart for DOCSL.XC
  • Previous Close 80.95
  • Open 80.70
  • Bid 79.20 x --
  • Ask 79.35 x --
  • Day's Range 78.68 - 80.70
  • 52 Week Range 45.00 - 88.00
  • Volume 720,003
  • Avg. Volume 358,810
  • Market Cap (intraday) 761.469M
  • Beta (5Y Monthly) 0.15
  • PE Ratio (TTM) 7,895.00
  • EPS (TTM) 0.01
  • Earnings Date Jun 5, 2025
  • Forward Dividend & Yield 0.03 (3.27%)
  • Ex-Dividend Date Aug 28, 2025
  • 1y Target Est --

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company was founded in 1945 and is based in London, the United Kingdom.

www.drmartensplc.com

2,348

Full Time Employees

March 30

Fiscal Year Ends

Recent News: DOCSL.XC

View More

Performance Overview: DOCSL.XC

Trailing total returns as of 6/11/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

DOCSL.XC
8.72%
FTSE 100 (^FTSE)
8.46%

1-Year Return

DOCSL.XC
5.71%
FTSE 100 (^FTSE)
8.79%

3-Year Return

DOCSL.XC
68.54%
FTSE 100 (^FTSE)
21.14%

5-Year Return

DOCSL.XC
70.89%
FTSE 100 (^FTSE)
45.87%

Compare To: DOCSL.XC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DOCSL.XC

View More

Valuation Measures

Annual
As of 6/9/2025
  • Market Cap

    781.72M

  • Enterprise Value

    1.03B

  • Trailing P/E

    155.85

  • Forward P/E

    18.12

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.96

  • Price/Book (mrq)

    2.05

  • Enterprise Value/Revenue

    1.26

  • Enterprise Value/EBITDA

    9.01

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.57%

  • Return on Assets (ttm)

    4.12%

  • Return on Equity (ttm)

    1.23%

  • Revenue (ttm)

    787.6M

  • Net Income Avi to Common (ttm)

    4.5M

  • Diluted EPS (ttm)

    0.01

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    155.9M

  • Total Debt/Equity (mrq)

    110.29%

  • Levered Free Cash Flow (ttm)

    164.56M

Research Analysis: DOCSL.XC

View More

Company Insights: DOCSL.XC

Research Reports: DOCSL.XC

View More

People Also Watch